Patient Guide: Phase 1, first-in-human study of MGC026, a B7-H3-targeted antibody-drug conjugate (ADC) in advanced solid tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 3 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT0624270
Status: 🟢 Enrolling Now
Condition: advanced solid tumors, squamous cell carcinoma of the head and neck, endometrial cancer, melanoma, soft tissue sarcoma
Phase: Phase I

Find a Study Location Near You

This study is available at 3 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • ,
  • ,
  • ,

Loading interactive enrollment tools...

The full interactive experience will load momentarily